000 01506 a2200373 4500
005 20250516125136.0
264 0 _c20130607
008 201306s 0 0 eng d
022 _a1744-8379
024 7 _a10.1586/erp.12.71
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBucsics, Anna
245 0 0 _aInfluence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries.
_h[electronic resource]
260 _bExpert review of pharmacoeconomics & outcomes research
_cDec 2012
300 _a809-19 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAmbulatory Care
_xstatistics & numerical data
650 0 4 _aAngiotensin II Type 1 Receptor Blockers
_xadministration & dosage
650 0 4 _aAustria
650 0 4 _aDrug Combinations
650 0 4 _aDrug Costs
650 0 4 _aDrugs, Generic
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aLosartan
_xadministration & dosage
650 0 4 _aPatents as Topic
650 0 4 _aPractice Patterns, Physicians'
_xstatistics & numerical data
700 1 _aGodman, Brian
700 1 _aBurkhardt, Thomas
700 1 _aSchmitzer, Manuela
700 1 _aMalmström, Rickard E
773 0 _tExpert review of pharmacoeconomics & outcomes research
_gvol. 12
_gno. 6
_gp. 809-19
856 4 0 _uhttps://doi.org/10.1586/erp.12.71
_zAvailable from publisher's website
999 _c22357773
_d22357773